AWM
SANA icon

Activest Wealth Management’s Sana Biotechnology SANA Stock Holding History

Activest Wealth Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,300
Closed -$52.5K – 1478
2026
Q1 		$46.9K Hold
16,300
– – 0.01% 343
2025
Q4 		$66.3K Buy
+16,300
New +$73K 0.01% 281

Other funds holding SANA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
BCA
Bay Colony Advisors Concord, Massachusetts $903M AUM 33.67% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Activest Wealth Management's SANA Position: Q2 2026 in Review

Activest Wealth Management sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 16,300 shares — an estimated $52.5K sold.

Activest Wealth Management first reported a position in SANA in Q4 2025 and held it in 2 quarters. The position peaked at $66.3K in Q4 2025. 8 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Activest Wealth Management reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Activest Wealth Management sold 16,300 Sana Biotechnology shares in Q2 2026, an estimated $52.5K.
  • Activest Wealth Management first reported a position in Sana Biotechnology in Q4 2025 and held it in 2 quarters.
  • Activest Wealth Management's Sana Biotechnology position peaked at $66.3K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.